Makoto Shiozaki

Title: The Innovations of Makoto Shiozaki

Introduction

Makoto Shiozaki is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds and their medical applications. With a total of 5 patents to his name, Shiozaki continues to push the boundaries of medical science.

Latest Patents

Among his latest patents, Shiozaki has developed dihydropyrimidin-2-one compounds, which are described as a compound of Formula [I] or a pharmaceutically acceptable salt thereof. Each symbol in the formula is defined in the specification. Additionally, he has created nitrogen-containing spirocyclic compounds, which have pharmaceutical uses in treating organ transplant rejection, graft versus host reaction after transplantation, autoimmune diseases, allergic diseases, and chronic myeloproliferative diseases.

Career Highlights

Shiozaki is currently employed at Japan Tobacco Inc., where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing medical treatments and improving patient outcomes.

Collaborations

Some of his notable coworkers include Masahiro Yokota and Katsuya Maeda, who contribute to the collaborative environment that fosters innovation at Japan Tobacco Inc.

Conclusion

Makoto Shiozaki's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his role as a key innovator in medical science. His work continues to impact the industry positively.